KMDA
Kamada
NASDAQ: KMDA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$8.14
+0.37% today
Updated 2026-04-30
Market cap
$474.09M
P/E ratio
23.43
P/S ratio
2.63x
EPS (TTM)
$0.35
Dividend yield
3.05%
52W range
$6 – $9
Volume
0.1M
Kamada (KMDA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
11.20%
Operating margin
7.95%
ROE
7.64%
ROA
4.37%
Debt/equity
0.04x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2007 | $13.44M | $-22.90M | 23.52% | -121.42% | -170.39% |
| 2008 | $15.21M | $-12.45M | 0.47% | -112.02% | -81.81% |
| 2009 | $14.98M | $-22.03M | -5.66% | -109.31% | -147.09% |
| 2010 | $36.27M | $-15.17M | 16.74% | -29.59% | -41.83% |
| 2011 | $55.92M | $-3.49M | 28.11% | -4.14% | -6.25% |
| 2012 | $72.67M | $260000.00 | 31.23% | 5.83% | 0.36% |
| 2013 | $70.62M | $443000.00 | 37.39% | 5.24% | 0.63% |
| 2014 | $71.92M | $-12.64M | 21.72% | -15.16% | -17.57% |
| 2015 | $70.11M | $-11.27M | 22.83% | -16.29% | -16.07% |
| 2016 | $77.49M | $-6.73M | 27.94% | -7.54% | -8.69% |
| 2017 | $102.83M | $6.90M | 31.21% | 7.24% | 6.71% |
| 2018 | $114.47M | $22.30M | 36.23% | 16.82% | 19.48% |
| 2019 | $127.19M | $22.25M | 39.11% | 17.91% | 17.49% |
| 2020 | $133.25M | $17.14M | 35.69% | 14.44% | 12.86% |
| 2021 | $103.64M | $-2.23M | 29.26% | -0.67% | -2.15% |
| 2022 | $129.34M | $-2.32M | 36.11% | 3.50% | -1.79% |
| 2023 | $142.52M | $8.28M | 38.94% | 7.06% | 5.81% |
| 2024 | $160.95M | $14.46M | 43.47% | 12.46% | 8.99% |
| 2025 | $195.34M | $21.86M | 40.08% | 14.54% | 11.19% |